Crescent Capital BDC, Inc. Quarterly Earnings Presentation September 30, 2021 Disclaimer and Forward-Looking Statement 2 This presentation (the "Presentation") has been prepared by Crescent Capital BDC, Inc. (together with its consolidated subsidiaries, "CCAP," "Crescent BDC" or the "Company") and may be used for informational purposes only. This Presentation contains summaries of certain financial and statistical information about the Company and should be viewed in conjunction with the Company's most rece ...

Table of Contents Title of each classTrading Symbol Name of each exchange on which registered Common Stock, $0.001 par value per share CCAP The Nasdaq Stock Market LLC Securities registered pursuant to Section 12(g) of the Act: None UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 O ...

Crescent Capital BDC, Inc. (NASDAQ:CCAP) Q2 2021 Earnings Conference Call August 12, 2021 12:00 PM ET Company Participants Dan McMahon - Investor Relations Jason Breaux - Chief Executive Officer Gerhard Lombard - Chief Financial Officer Conference Call Participants Robert Dodd - Raymond James Operator Good day and thank you for standing by. Welcome to the Second Quarter 2021 Crescent Capital BDC Earnings Conference Call. [Operator Instructions] I’d now like to hand the call over to Dan McMahon, Head of Inve ...

Financial Performance - Adjusted net investment income for Q2 2021 was $14.8 million, or $0.53 per share, compared to $13.0 million, or $0.46 per share, in the previous quarter[12] - Net investment income for Q2 2021 was $11.0 million, or $0.39 per share, compared to $11.4 million, or $0.41 per share, in the prior quarter[12] - Net realized and unrealized gains on investments for Q2 2021 were $21.6 million, or $0.77 per share, compared to $10.1 million, or $0.36 per share, for the prior quarter[12] - Net asset value per share as of June 30, 2021, was $20.98, compared to $20.24 as of March 31, 2021[13] - Total net assets increased to $591 million as of June 30, 2021[8,15] Portfolio Composition - Total portfolio investments were $1,095 million as of June 30, 2021[9] - The portfolio consists of 130 portfolio companies across 20 industries[13] - 80% of the portfolio is comprised of senior secured first lien and unitranche first lien investments by fair value[13,28] - 99.6% of the debt investments are floating rate[17,27] Liquidity and Capital Structure - The company has a strong liquidity profile with $25.8 million in cash and cash equivalents and restricted cash[13,18] - Undrawn debt capacity is $220.1 million[13,32] - The debt-to-equity ratio is 0.87x[8,15]

Table of Contents Title of each classTrading Symbol Name of each exchange on which registered UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission file number 814-01132 Crescent Capital BDC, Inc. (Exact Name of Registrant as Specifi ...

Crescent Capital BDC, Inc. (NASDAQ:CCAP) Q1 2021 Earnings Conference Call May 13, 2021 12:00 PM ET Company Participants Daniel McMahon - Investor Relations Jason Breaux - Chief Executive Officer Gerhard Lombard - Chief Financial Officer Conference Call Participants Robert Dodd - Raymond James Operator Good day and thank you for standing by. Welcome to the Q1 Crescent Capital BDC Earnings Call. At this time, all participants are in a listen-only mode. [Operator Instructions] I would now like to turn the call ...

Table of Contents Common Stock, $0.001 par value per share CCAP The Nasdaq Stock Market LLC Securities registered pursuant to Section 12(g) of the Act: None UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission file number 814-01132 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission file number 814-01132 Crescent Capital BDC, Inc. (Exact Name of Registrant as Specified in Its Charter) Maryland 47-3162282 (State or Other Jurisdiction of Incorporation or Organizati ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission file number 814-01132 Crescent Capital BDC, Inc. (Exact Name of Registrant as Specified in Its Charter) Maryland 47-316228 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission file number 814-01132 Crescent Capital BDC, Inc. (Exact Name of Registrant as Specified in Its Charter) Maryland 47-3162282 (St ...